These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23104773)

  • 1. Drug therapy for children with tuberculosis.
    Ormerod LP
    Arch Dis Child; 2012 Dec; 97(12):1097-101. PubMed ID: 23104773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial T-SPOT.TB and quantiFERON-TB-Gold In-Tube assays to monitor response to antitubercular treatment in Italian children with active or latent tuberculosis infection.
    Chiappini E; Bonsignori F; Mangone G; Galli L; Mazzantini R; Sollai S; Azzari C; de Martino M
    Pediatr Infect Dis J; 2012 Sep; 31(9):974-7. PubMed ID: 22572749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis in humans and its epidemiology, diagnosis and treatment in the United States.
    LoBue PA; Enarson DA; Thoen TC
    Int J Tuberc Lung Dis; 2010 Oct; 14(10):1226-32. PubMed ID: 20843412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quantitative benefit-risk analysis of isoniazid for treatment of latent tuberculosis infection using incremental benefit framework.
    Sadatsafavi M; Marra C; Marra F; Moran O; FitzGerald JM; Lynd L
    Value Health; 2013; 16(1):66-75. PubMed ID: 23337217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of 3 months of rifampicin and isoniazid chemoprophylaxis for the treatment of latent tuberculosis infection in children.
    Bright-Thomas R; Nandwani S; Smith J; Morris JA; Ormerod LP
    Arch Dis Child; 2010 Aug; 95(8):600-2. PubMed ID: 20530147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial interferon-γ release assay in children with latent tuberculosis infection and children with tuberculosis.
    Nenadić N; Kirin BK; Letoja IZ; Plavec D; Topić RZ; Dodig S
    Pediatr Pulmonol; 2012 Apr; 47(4):401-8. PubMed ID: 21901862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and management challenges for childhood tuberculosis in the era of HIV.
    Marais BJ; Graham SM; Cotton MF; Beyers N
    J Infect Dis; 2007 Aug; 196 Suppl 1():S76-85. PubMed ID: 17624829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and management of latent tuberculosis in liver transplant patients.
    Jafri SM; Singal AG; Kaul D; Fontana RJ
    Liver Transpl; 2011 Mar; 17(3):306-14. PubMed ID: 21384513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF-α/IL-2 ratio discriminates latent from active tuberculosis in immunocompetent children: a pilot study.
    Gourgouillon N; de Lauzanne A; Cottart CH; Curis E; Debord C; Guérin-El Khourouj V; Pédron B; Faye A; Sterkers G
    Pediatr Res; 2012 Oct; 72(4):370-4. PubMed ID: 22797138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compliance to treatment of latent tuberculosis infection in a region of Israel.
    Bibi H; Weiler-Ravell D; Shoseyov D; Feigin I; Arbelli Y; Chemtob D
    Isr Med Assoc J; 2002 Jan; 4(1):13-6. PubMed ID: 11802301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis in children and its management.
    Abernathy RS
    Semin Respir Infect; 1989 Sep; 4(3):232-42. PubMed ID: 2688006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contact tracing and prophylaxis of tuberculosis].
    Seersholm N; Wilcke T
    Ugeskr Laeger; 2011 Mar; 173(12):883-6. PubMed ID: 21419057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active case finding and prevention of tuberculosis among a cohort of contacts exposed to infectious tuberculosis cases in New York City.
    Anger HA; Proops D; Harris TG; Li J; Kreiswirth BN; Shashkina E; Ahuja SD
    Clin Infect Dis; 2012 May; 54(9):1287-95. PubMed ID: 22412056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment.
    Kobashi Y; Mouri K; Yagi S; Obase Y; Miyashita N; Oka M
    J Infect; 2009 Mar; 58(3):197-204. PubMed ID: 18848730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Latent tuberculosis infection: recommendations for preventive therapy in adults in Germany].
    Schaberg T; Hauer B; Haas WH; Hohlfeld J; Kropp R; Loddenkemper R; Loytved G; Magdorf K; Rieder HL; Sagebiel D
    Pneumologie; 2004 Apr; 58(4):255-70. PubMed ID: 15098162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse events and development of tuberculosis after 4 months of rifampicin prophylaxis in a tuberculosis outbreak.
    Lee SH; Yim JJ; Kim HJ; Shim TS; Seo HS; Cho YS; Lee HK; Lee YM; Lee EJ; Lew WJ
    Epidemiol Infect; 2012 Jun; 140(6):1028-35. PubMed ID: 21835069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma cytokines and chemokines differentiate between active disease and non-active tuberculosis infection.
    Mihret A; Bekele Y; Bobosha K; Kidd M; Aseffa A; Howe R; Walzl G
    J Infect; 2013 Apr; 66(4):357-65. PubMed ID: 23178506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active tuberculosis and Mycobacterium tuberculosis latent infection in patients with HIV/AIDS.
    Gutierrez EB; Gomes V; Picone CM; Suga H; Atomiya AN
    HIV Med; 2009 Oct; 10(9):564-72. PubMed ID: 19785665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis.
    Diel R; Loddenkemper R; Meywald-Walter K; Niemann S; Nienhaus A
    Am J Respir Crit Care Med; 2008 May; 177(10):1164-70. PubMed ID: 18276940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.
    Alsleben N; Ruhwald M; Rüssmann H; Marx FM; Wahn U; Magdorf K
    Scand J Infect Dis; 2012 Apr; 44(4):256-62. PubMed ID: 22103555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.